DEA Puts Epidiolex In Schedule 5 Category
GW Pharmaceuticals’ (GW) cannabidiol (CBD) formulation Epidiolex has cleared the final step in the regulatory approval process and been transferred …
September 27, 2018/
Cannabis, Legalization, Medical, regulation, Science and medicine/